http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2065278-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65f6765a6f0387cfcb75bc6a09213161
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-04
filingDate 1993-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1995-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5904e9447f6a701fcc6d3980f268190
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e05a2a22f086fa171ac91b3013a61d10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ab3dfa6788426778d7b31393650c2ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c230e65828543dc82dca60bbe3c8c92d
publicationDate 1995-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2065278-B1
titleOfInvention LEVOBUNOLOL ENANTIOSELECTIVE PROCEDURE FOR OBTAINING.
abstract THE INVENTION IS REFERRED TO A NEW PROCEDURE FOR OBTAINING THE KNOWN BETAADRENERGICO BLOCKING AGENT LEVOBUNOLOL, INDUSTRIALALLY ADVANTAGEOUS, WHICH DOES NOT NEED THE RESOLUTION OF THE RACEMICO BUNOLOL, SUIORI YEURY, WITH AN INTERMEDIATE REINFORCEMENT. THE PROCEDURE OF THE PRESENT INVENTION CONSISTS OF REACTIONING 5-HYDROXY-3,4DIHYDRO-1 (2H) -NAPHTHALENONE WITH R - (-) - EPICLORHIDRINA, IN THE SINE OF A SUITABLE SOLVENT IN THE PRESENCE OF A STRONG BASE AND ALREADY A TEMPERATURE HIGHER THAN 90GC, TO OBTAIN, WITH AN OPTIC PURITY OF HIGHER THAN 95%, THE INTERMEDIATE CHIRAL OXIRANE (S) -5 (2,3-EPOXIPROPOXI) -3,4-DIHYDRO-1 (2H) -NAPHTHALENONE AND, AFTER, HAVE THE INTERMEDIATE CHIRAL OXIRANE REACT WITH TERC-BUTYLAMINE.
priorityDate 1993-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419695581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID39468

Total number of triples: 23.